BRMS1 and melanoma: When coupled with our previously demonstrated associations between cell cycle regulators, numbers of mitosis and disease progression [21,22,24], the data presented further strengthen the hypothesis that cytoplasmic BRMS1 is associated with a less aggressive melanoma phenotype (i.e., thinner tumors, less ulcerated, longer survival).